Filed: 11/13/2024ACC: 0001839882-24-038904
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 84 equity positions with a total reported market value of $732.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
84
Positions
$732.76M
Total AUM (reported)
104.60M
Total Shares
Allocation by class
COM$424.67M58.0%
SPONSORED ADS$79.28M10.8%
COM NEW$45.26M6.2%
SHS$44.65M6.1%
COMMON STOCK$33.40M4.6%
CL A$19.23M2.6%
SPON ADS$16.34M2.2%
Portfolio Concentration
Top 3$130.94M17.9%
4–10$195.93M26.7%
11–25$203.07M27.7%
Rest$202.82M27.7%
Top 3 weight
17.9%
Top 10 weight
44.6%
Voting Authority Distribution
Total shares with voting rights: 104.60M
Sole
Full voting authority
104.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole84
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings84
Rows:
XENON PHARMACEUTICALS INC
SOLEShares1.14M
TypeSH
Market value$45.04M
6.15%
Sole
1.14M
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares2.40M
TypeSH
Market value$43.25M
5.90%
Sole
2.40M
Shared
0.00
None
0.00
CASSAVA SCIENCES INC
SOLEShares1.45M
TypeSH
Market value$42.65M
5.82%
Sole
1.45M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares664.20K
TypeSH
Market value$39.01M
5.32%
Sole
664.20K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares337.50K
TypeSH
Market value$34.53M
4.71%
Sole
337.50K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares400K
TypeSH
Market value$33.40M
4.56%
Sole
400K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1M
TypeSH
Market value$27.99M
3.82%
Sole
1M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$21.22M
2.90%
Sole
100K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares400K
TypeSH
Market value$20.44M
2.79%
Sole
400K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares860.40K
TypeSH
Market value$19.33M
2.64%
Sole
860.40K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares435K
TypeSH
Market value$19.23M
2.62%
Sole
435K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares650K
TypeSH
Market value$18.70M
2.55%
Sole
650K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares4.50M
TypeSH
Market value$16.34M
2.23%
Sole
4.50M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares965.61K
TypeSH
Market value$15.44M
2.11%
Sole
965.61K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares2.82M
TypeSH
Market value$14.76M
2.01%
Sole
2.82M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares498.42K
TypeSH
Market value$14.66M
2.00%
Sole
498.42K
Shared
0.00
None
0.00
OMEROS CORP
SOLEShares21.52M
TypePRN
Market value$14.64M
2.00%
Sole
21.52M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares687.78K
TypeSH
Market value$13.44M
1.83%
Sole
687.78K
Shared
0.00
None
0.00
COHERUS BIOSCIENCES INC
SOLEShares16.63M
TypePRN
Market value$13.05M
1.78%
Sole
16.63M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares290.45K
TypeSH
Market value$12.57M
1.72%
Sole
290.45K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares525K
TypeSH
Market value$11.94M
1.63%
Sole
525K
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares1.40M
TypeSH
Market value$11.48M
1.57%
Sole
1.40M
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares12.25M
TypePRN
Market value$9.62M
1.31%
Sole
12.25M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares303K
TypeSH
Market value$8.64M
1.18%
Sole
303K
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares349.84K
TypeSH
Market value$8.57M
1.17%
Sole
349.84K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XENON PHARMACEUTICALS INCSOLE | COM | 1.14M | SH | $45.04M 6.15% | 1.14M | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 2.40M | SH | $43.25M 5.90% | 2.40M | 0.00 | 0.00 |
CASSAVA SCIENCES INCSOLE | COM | 1.45M | SH | $42.65M 5.82% | 1.45M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 664.20K | SH | $39.01M 5.32% | 664.20K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 337.50K | SH | $34.53M 4.71% | 337.50K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 400K | SH | $33.40M 4.56% | 400K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 1M | SH | $27.99M 3.82% | 1M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 100K | SH | $21.22M 2.90% | 100K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 400K | SH | $20.44M 2.79% | 400K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 860.40K | SH | $19.33M 2.64% | 860.40K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 435K | SH | $19.23M 2.62% | 435K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 650K | SH | $18.70M 2.55% | 650K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 4.50M | SH | $16.34M 2.23% | 4.50M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 965.61K | SH | $15.44M 2.11% | 965.61K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 2.82M | SH | $14.76M 2.01% | 2.82M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 498.42K | SH | $14.66M 2.00% | 498.42K | 0.00 | 0.00 |
OMEROS CORPSOLE | NOTE 5.250% 2/1 | 21.52M | PRN | $14.64M 2.00% | 21.52M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 687.78K | SH | $13.44M 1.83% | 687.78K | 0.00 | 0.00 |
COHERUS BIOSCIENCES INCSOLE | NOTE 1.500% 4/1 | 16.63M | PRN | $13.05M 1.78% | 16.63M | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 290.45K | SH | $12.57M 1.72% | 290.45K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 525K | SH | $11.94M 1.63% | 525K | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 1.40M | SH | $11.48M 1.57% | 1.40M | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | NOTE 3.000%10/1 | 12.25M | PRN | $9.62M 1.31% | 12.25M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 303K | SH | $8.64M 1.18% | 303K | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 349.84K | SH | $8.57M 1.17% | 349.84K | 0.00 | 0.00 |
Page 1 of 4